ghmm, do you follow ZGEN, perchance? Looking at the calendar and doublechecking my picture of ZGEN, it's clear that atacicept's trials need to be removed (or moved) from the ZGEN listing since it was fully out-licensed to Merck Serono last fall. Someone who follows ZGEN more closely than I should probably take care of it and ensure the IL 21 info is up to date. Regards, Corp